Hyperlipidemia Patient Compliance - Economic and Clinical Implications for the Pharmaceutical Industry

Table of Contents

I. EXECUTIVE SUMMARY

• Compliance Defined
• Consequences of Noncompliance
• Measuring Compliance
• Compliance Rates
• Factors Influencing Compliance
• Strategies for Improving Compliance

II. PHARMACEUTICAL INDUSTRY IMPLICATIONS

• Implications for Clinical Trial Design
• Implications for Product Development
• Implications for Pharmaceutical Marketing

III. METHODOLOGY

IV. HYPERLIPIDEMIA

1. Description
2. Patient Characteristics and Prevalence
3. Approaches to Treatment
4. Compliance Issues
5. Compliance Rates
   • Study 1: Exercise Treatment Compliance
   • Study 2: Compliance with Statins
   • Study 3: Key Risk Factor for Noncompliance
   • Study 4: Laboratory Visit Compliance
   • Study 5: Long-Term Compliance with a Cholesterol-Lowering Diet
6. Cost of Noncompliance
7. Compliance Strategies
8. Patient Perspectives
   • Key Findings
   • Patient Quotes

V. REFERENCES